Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Illinois had at least 103 outbreaks of the stomach bug norovirus in November and December – a dramatic increase from previous ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. But there are things ...

Dr. Ben Weston, chief health policy advisor for Milwaukee County, joins Lake Effect's Joy Powers to talk about how you can ...

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Norovirus cases in hospitals are 80 per cent higher than the same period last year, adding to hospital pressure across the ...

Flu rates have dropped since their peak but remain almost 2.5 times higher than last year, with 3,833 patients in hospital ...